Stay updated on Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.

Latest updates to the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedIn the Taiwan locations section, the site label changed from Taoyuan District to Taoyuan, Taiwan, 33305 to reflect a city-level designation.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page footer revision was updated from **v3.5.0** to **v3.5.3**, indicating a website/version control update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check42 days agoChange DetectedPadova, Italy, 35128 was added to the locations list, and Padua, Italy, 35128 was removed.SummaryDifference0.0%

- Check57 days agoChange DetectedLocation entry for Italy (80131) updated from Napoli to Naples. Page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check71 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. This is a metadata update with no changes to the study content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.